The increasing value of eHealth in the delivery of patient-centred cancer care

FJ Penedo, LB Oswald, JP Kronenfeld… - The Lancet …, 2020 - thelancet.com
The increasing use of eHealth has ushered in a new era of patient-centred cancer care that
moves beyond the traditional in-person care model to real-time, dynamic, and technology …

Patient-reported outcomes in cancer care—hearing the patient voice at greater volume

TW LeBlanc, AP Abernethy - Nature reviews Clinical oncology, 2017 - nature.com
Recording of patient-reported outcomes (PROs) enables direct measurement of the
experiences of patients with cancer. In the past decade, the use of PROs has become a …

Systemic treatment of hepatocellular carcinoma: An EASL position paper

J Bruix, SL Chan, PR Galle, L Rimassa, B Sangro - Journal of hepatology, 2021 - Elsevier
The last 5 years have witnessed relevant advances in the systemic treatment of
hepatocellular carcinoma. New data have emerged since the development of the EASL …

Experiences with the standardized classification of surgical complications (Clavien-Dindo) in general surgery patients

M Bolliger, JA Kroehnert, F Molineus, D Kandioler… - European Surgery, 2018 - Springer
Summary Background The standardized Clavien-Dindo classification of surgical
complications is applied as a simple and widely used tool to assess and report …

Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non …

MC Garassino, S Gadgeel, E Esteban, E Felip… - The Lancet …, 2020 - thelancet.com
Background Pembrolizumab plus pemetrexed–platinum led to superior overall survival and
progression-free survival, and a higher proportion of patients with a confirmed complete or …

Approach for classification and severity grading of long-term and late-onset health events among childhood cancer survivors in the St. Jude Lifetime Cohort

MM Hudson, MJ Ehrhardt, N Bhakta, M Baassiri… - … , biomarkers & prevention, 2017 - AACR
Abstract Characterization of toxicity associated with cancer and its treatment is essential to
quantify risk, inform optimization of therapeutic approaches for newly diagnosed patients …

Harnessing consumer smartphone and wearable sensors for clinical cancer research

CA Low - NPJ Digital Medicine, 2020 - nature.com
As smartphones and consumer wearable devices become more ubiquitous, there is a
growing opportunity to capture rich mobile sensor data continuously, passively, and in real …

[HTML][HTML] Addressing the quality of life needs of older patients with cancer: a SIOG consensus paper and practical guide

F Scotté, P Bossi, E Carola, T Cudennec… - Annals of …, 2018 - Elsevier
Around 60% of people living with cancer are aged 65 years or older. Older cancer patients
face a unique set of age-associated changes, comorbidities and circumstances that impact …

[HTML][HTML] Past and current practice of patient-reported outcome measurement in randomized cancer clinical trials: a systematic review

JM Giesinger, F Efficace, N Aaronson, M Calvert… - Value in Health, 2021 - Elsevier
Objectives In our systematic review, we assessed past and current practice of patient-
reported outcome (PRO) measurement in cancer randomized, controlled trials (RCTs) …

Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies

G Thanarajasingam, LM Minasian, F Baron… - The Lancet …, 2018 - thelancet.com
Tremendous progress in treatment and outcomes has been achieved across the whole
range of haematological malignancies in the past two decades. Although cure rates for …